Comprehensive STD Panel Testing Components
A comprehensive STD panel typically includes tests for syphilis, gonorrhea, chlamydia, HIV, and hepatitis B, with additional tests based on risk factors and symptoms. 1
Core STD Panel Components
Standard Tests
- Syphilis: Serologic testing (RPR or other tests)
- Gonorrhea: Testing for Neisseria gonorrhoeae
- Urethral/urine specimens for all patients
- Rectal specimens for MSM (men who have sex with men)
- Pharyngeal specimens for MSM
- Chlamydia: Testing for Chlamydia trachomatis
- Urethral/urine specimens for all patients
- Rectal specimens for MSM
- Cervical specimens for women
- HIV: Serologic testing
- Hepatitis B: Surface antigen (HBsAg) testing
Additional Tests Based on Risk Assessment
- Bacterial vaginosis: For women with symptoms or risk factors
- Trichomoniasis: For women with symptoms
- Herpes simplex virus: For patients with genital ulcers
- Hepatitis C: For patients with risk factors (injection drug use, etc.)
Risk Assessment Questions
When a patient requests STD testing, the following questions should be asked to determine appropriate testing 1:
Sexual history:
- Number and gender of recent sexual partners
- Types of sexual contact (oral, vaginal, anal)
- Use of protection (condoms, dental dams)
- History of previous STDs
Risk factors:
- New or multiple sexual partners
- Partners with known STDs
- Injection drug use
- Sex work or partners who engage in sex work
- Men who have sex with men
Symptoms assessment:
- Genital discharge, lesions, or rash
- Dysuria (painful urination)
- Pelvic or abdominal pain
- Abnormal vaginal bleeding
- Testicular pain or swelling
Special Considerations for High-Risk Groups
Men Who Have Sex With Men (MSM)
- Extragenital testing is crucial - rectal and pharyngeal specimens should be collected for gonorrhea and chlamydia 2
- Testing positivity rates are significant (3.0%-9.8%) even in asymptomatic patients 2
Pregnant Women
Pregnant women require comprehensive screening due to potential fetal impacts 1:
- Syphilis testing in early pregnancy and possibly third trimester
- Hepatitis B testing at first prenatal visit
- Chlamydia and gonorrhea testing, especially for women under 25 or with risk factors
- HIV testing at first prenatal visit
- Bacterial vaginosis testing for those at risk for preterm labor
Common Pitfalls in STD Testing
Inadequate site sampling: Failing to test extragenital sites (rectal, pharyngeal) in MSM leads to missed infections 2
Overlooking asymptomatic infections: Many STDs present without symptoms but remain transmissible and can cause complications
Inadequate follow-up testing: Patients with positive chlamydia should be retested 3 months after treatment to check for reinfection
Not addressing partner notification: All patients with STDs should be counseled about notifying partners for testing and treatment 1
Missing reportable diseases: Providers must be aware that syphilis, gonorrhea, and HIV/AIDS are reportable in all states, while chlamydia is reportable in most states 1
By following these comprehensive testing guidelines, providers can effectively screen for and treat STDs, reducing transmission and preventing long-term complications that affect morbidity, mortality, and quality of life.